Y-Intercept (HK)
LEGN icon

Y-Intercept (HK)’s Legend Biotech LEGN Stock Holding History

Y-Intercept (HK)’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$555K Buy
27,906
+2,972
+12% +$63.4K 0.01% 1258
2026
Q2 		$720K Sell
24,934
-198,362
-89% -$5.35M 0.01% 1182
2026
Q1 		$4.04M Buy
+223,296
New +$4.26M 0.08% 416
2024
Q4 		– Sell
-9,391
Closed -$458K – 1446
2024
Q3 		$458K Buy
+9,391
New +$500K 0.03% 815
2024
Q2 		– Sell
-4,570
Closed -$256K – 1669
2024
Q1 		$256K Buy
+4,570
New +$276K 0.02% 1039
2023
Q3 		– Sell
-5,355
Closed -$370K – 1355
2023
Q2 		$370K Buy
+5,355
New +$350K 0.04% 692

Other funds holding LEGN

Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
NLB Skladi upravljanje premozenja
NLB Skladi upravljanje premozenja Ljubljana $2.71B AUM 53.8% 1-Year Est. Return
PensionDanmark
PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Toth Financial Advisory
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Aspect Partners
Aspect Partners Fairfax, Virginia $264M AUM 15.76% 1-Year Est. Return

Y-Intercept (HK)'s LEGN Position: Q3 2026 in Review

Y-Intercept (HK) increased its Legend Biotech (LEGN) stake by 12% in Q3 2026, buying an estimated $63.4K and bringing the position to 27,906 shares worth $555K. The position accounts for 0.01% of the portfolio, ranked #1258.

Y-Intercept (HK) first reported a position in LEGN in Q2 2023 and has held it in 6 quarters since. The position peaked at $4.04M in Q1 2026. 16 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Y-Intercept (HK) held 27,906 shares of Legend Biotech worth $555K as of Q3 2026.
  • Y-Intercept (HK) bought 2,972 Legend Biotech shares in Q3 2026, an estimated $63.4K.
  • Legend Biotech made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1258 holding.
  • Y-Intercept (HK) first reported a position in Legend Biotech in Q2 2023 and has held it in 6 quarters since.
  • Y-Intercept (HK)'s Legend Biotech position peaked at $4.04M in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.